BioCryst to Report Third Quarter 2024 Financial Results on November 4
Provided By GlobeNewswire
Last update: Oct 21, 2024
RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2024 financial results on Monday, November 4, 2024.
Read more at globenewswire.com
